Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06958146

Azithromycin for Preventing Maternal and Neonatal Infections During Labor.

In this study, we want to see the role of the antibiotic, azithromycin, in preventing maternal and neonatal infections, if the drug is given intrapartum to the mother

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • pregnant ladies with no risk factors for sepsis who go into spontaneous labor or induced labor

Exclusion criteria

  • pregnant with risk factors for sepsis like maternal fever , raised WBC count, chorioamnionitis, or having. history of any adverse even with macrolides

Treatment and study plan

oral azithromycin

Drug

we will be administering single-dose oral azithromycin to ladies who go into labor and have no risk factors for sepsis, as there is increased risk of postpartum sepsis in both mother and neonate after normal vaginal delivery in low-income and middle-income countries

no azithromycin

Other

participants in this arm will be given only standard labor care and no oral azithromycin

Primary outcomes

  1. maternal infections

    Time frame: birth to 6 weeks post partum

Secondary outcomes

  1. neonatal infections

    Time frame: birth to 6 weeks post partum

Sponsors and collaborators

Lead sponsor

Armed Forces Hospital, Pakistan

Other

Registry information

Official study title

Impact of Single Dose Azithromycin During Labor on Maternal and Neonatal Infections

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
May 6, 2025
Registry last updated
May 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.